RETRACTED: MicroRNA-663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4 (Retracted article. See vol. 27, pg. 108, 2023)

被引:6
作者
Liu, Yingying [1 ]
Jiao, Dan [2 ]
Tian, Zhen [3 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Nephrol, Changchun 130033, Jilin, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Ultrasound, Changchun 130033, Jilin, Peoples R China
[3] Jilin Univ, China Japan Union Hosp, Dept Cardiol, 126 Xiantai Rd, Changchun 130033, Jilin, Peoples R China
关键词
clear cell renal cell carcinoma; microRNA-663; proliferation; invasion; p21 activated kinase 4; CANCER; MIR-663; MIGRATION; GROWTH; EXPRESSION; PROMOTES; PROGNOSIS; APOPTOSIS;
D O I
10.3892/mmr.2018.9652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulating evidence has demonstrated that microRNAs (miRNAs) are key gene regulators and are abnormally expressed in clear cell renal cell carcinoma (ccRCC). The dysregulation of miRNAs has been implicated in the initiation and progression of ccRCC. Therefore, identification of ccRCC-associated miRNAs may facilitate the determination of promising therapeutic targets for anti-cancer treatment. In the present study, miRNA-663 (miR-663) expression was downregulated in ccRCC tissues and cell lines. Functional experiments suggested that restoration of miR-663 expression inhibited the proliferation and invasion of ccRCC cells. In addition, p21 activated kinase 4 (PAK4) was validated as a direct target of miR-663 in ccRCC cells. PAK4 was upregulated in ccRCC tissues, and the expression level of PAK4 was inversely correlated with the miR-663 expression level. PAK4 restoration partially attenuated the suppressive roles of miR-663 overexpression on the proliferation and invasion of ccRCC cells. The present results provide novel insight into the mechanism underlying the occurrence and development of ccRCC, suggesting that the miR-663/PAK4 axis may be a novel therapeutic target for treatment of patients with ccRCC.
引用
收藏
页码:711 / 718
页数:8
相关论文
共 49 条
  • [1] Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
    Abu Aboud, Omran
    Chen, Ching-Hsien
    Senapedis, William
    Baloglu, Erkan
    Argueta, Christian
    Weiss, Robert H.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) : 2119 - 2129
  • [2] A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF
    Ahmed, Tasneem
    Shea, Kerry
    Masters, John R. W.
    Jones, Gareth E.
    Wells, Claire M.
    [J]. CELLULAR SIGNALLING, 2008, 20 (07) : 1320 - 1328
  • [3] Al-Ali BM, 2012, ANTICANCER RES, V32, P3727
  • [4] A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer
    Albiges, Laurence
    Choueiri, Toni
    Escudier, Bernard
    Galsky, Matthew
    George, Dan
    Hofmann, Fabian
    Lam, Thomas
    Motzer, Robert
    Mulders, Peter
    Porta, Camillo
    Powles, Thomas
    Sternberg, Cora
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2015, 67 (01) : 100 - 110
  • [5] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [6] Biology of the p21-activated kinases
    Bokoch, GM
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 743 - 781
  • [7] Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma
    Cheville, JC
    Lohse, CM
    Zincke, H
    Weaver, AL
    Blute, ML
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (05) : 612 - 624
  • [8] miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2
    Fiori, Micol E.
    Villanova, Lidia
    Barbini, Chiara
    De Angelis, Maria Laura
    De Maria, Ruggero
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [9] MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1
    Fu, Hao
    Song, Wenke
    Chen, Xuancai
    Guo, Tao
    Duan, Bin
    Wang, Xinxi
    Tang, Yachun
    Huang, Liang
    Zhang, Chi
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 437 (1-2) : 143 - 152
  • [10] Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
    Fujii, Nakanori
    Hirata, Hiroshi
    Ueno, Koji
    Mori, Junichi
    Oka, Shintaro
    Shimizu, Kosuke
    Kawai, Yoshihisa
    Inoue, Ryo
    Yamamoto, Yoshiaki
    Matsumoto, Hiroaki
    Shimabukuro, Tomoyuki
    Udoh, Koichi
    Hoshii, Yoshinobu
    Dahiya, Rajvir
    Matsuyama, Hideyasu
    [J]. ONCOTARGET, 2017, 8 (66) : 109877 - 109888